Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARRY-371797 in Osteoarthritis of the Knee
NCT01366014Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jun 2011
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of emprumapimod in knee osteoarthritis (OA), sponsored by Pfizer. Started Jun 2011; status: completed.
02
Drugs
emprumapimod
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01366014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01366014.